.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The NATHEALTH healthcare leadership is entering a transformative new era for the fiscal year 2026–27. As the apex body representing the Indian healthcare industry, NATHEALTH recently announced strategic expansions to its governing team. Shankha Banerjee, CEO of Dr. Lal PathLabs, has taken the role of Treasurer. Meanwhile, Mandeep Singh Kumar, Managing Director and Vice President of Medtronic India, joins as Secretary. These appointments followed a significant Governing Council meeting aimed at strengthening the organization’s strategic influence. Consequently, the leadership expansion reflects a commitment to integrating diagnostics and medical technology into the core of India's health policy.
Sangita Reddy, Joint Managing Director of Apollo Hospitals, continues to lead the organization as President. The current leadership roster also includes Himanshu Baid as Senior Vice President and Varun Khanna as Vice President. This diverse group of experts brings a comprehensive understanding of the care continuum to the table. Furthermore, Siddhartha Bhattacharya will continue his role as Secretary General. He will focus on expanding regional stakeholder engagement and collaborating with policymakers. Therefore, the organization is well-positioned to drive systemic change across the entire healthcare ecosystem. These efforts align closely with the national vision of Viksit Bharat 2047, focusing on long-term patient wellbeing and safety.
Shankha Banerjee emphasized the growing importance of early intervention during his appointment remarks. He noted that data-driven decision-making is essential for addressing the rising burden of non-communicable diseases in India. Additionally, diagnostics will play a critical role in enabling early detection and guiding clinical decisions. Mandeep Singh Kumar highlighted that India’s healthcare ecosystem is currently at a pivotal moment. Evolving patient expectations and rapid innovation are driving significant shifts in care delivery. Consequently, fostering collaboration across the government and private industry remains a top priority. The team intends to build a future-ready healthcare system through enhanced public-private partnerships and improved clinical outcomes.
Q1: Who are the new appointees in the NATHEALTH leadership team?
Shankha Banerjee from Dr. Lal PathLabs was appointed as Treasurer, and Mandeep Singh Kumar from Medtronic India was appointed as Secretary for the 2026–27 term.
Q2: What is the primary objective of the expanded NATHEALTH team?
The team aims to drive systemic change in the healthcare ecosystem by focusing on diagnostics, medical technology, and preventive healthcare to support India's 2047 development goals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NATHEALTH appoints Shankha Banerjee and Mandeep Singh Kumar to its FY 2026-27 leadership team to drive diagnostic and medical technology innovation in India...
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
